ロード中...
miR-135a Reduces Osteosarcoma Pulmonary Metastasis by Targeting Both BMI1 and KLF4
Because of the modest response rate after surgery and chemotherapy, treatment of osteosarcoma (OS) remains challenging due to tumor recurrence and metastasis. miR-135a has been reported to act as an anticarcinogenic regulator of several cancers. However, its expression and function in osteosarcoma r...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8019936/ https://ncbi.nlm.nih.gov/pubmed/33828977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.620295 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|